Hisun's Sulbactam Sodium can sell in US again
Friday, 06 November 2015｜Source：CHINA CHAMBER OF COMMERCEFOR IMPORT&EXPORT OF MEDICINES &HEALTH PRODUCTS｜Author：
Zhejiang Hisun Pharmaceutical Co., Ltd announced on Nov. 5 that its Sulbactam Sodium (API) can enter US market again after receiving the import alert exemption. It received the import alert on Sep. 10 fot its 15 APIs (including Sulbactam Sodium). Now the other 14 APIs still can't enter US market. Hisun still can sell 15 APIs in US market now.
The sales value of its Sulbactam Sodium in US IS 9.24 million Yuan in 2014 and the sales value is 6.64 million Yuan in Jan to Oct. in 2015.
Source：Healthoo